In pursuit of drugs for American trypanosomiasis: evaluation of some "standards" in a mouse model.
K E Kinnamon, B T Poon, W L Hanson, V B Waits
Index: Proc. Soc. Exp. Biol. Med. 216(3) , 424-8, (1997)
Full Text: HTML
Abstract
Forty-nine "standard" compounds known to be useful in the treatment of other diseases were tested for their suppressive activity against the trypomastigotes of Trypanosoma cruzi-infected mice. The most active was the antidepressant protriptyline, which was almost three times as effective as the reference drug, nifurtimox. A major value of the present data is to demonstrate the refractoriness of the T. cruzi parasite against many of the drug standards that have known biological activity.
Related Compounds
Related Articles:
Protriptyline, chronic tension-type headaches, and weight loss in women.
1997-01-01
[Headache 37(7) , 433-6, (1997)]
1997-01-01
[Respiration 64 Suppl 1 , 35-8, (1997)]
The carotid body in the motorneuron response to protriptyline.
1993-07-01
[Respir. Physiol. 93(1) , 41-9, (1993)]
2010-09-20
[Chem. Res. Toxicol. 23(9) , 1497-503, (2010)]
1994-04-01
[Sleep 17(3) , 280-3, (1994)]